Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.650 USD | -6.41% |
|
-7.82% | +34.12% |
| Market Cap | 45.71M 39.66M 36.56M 34.26M 64.01M 4.38B 65.34M 436M 169M 2.11B 172M 168M 7.34B | P/E Ratio 2024 |
6.84x | P/E Ratio 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 44.38M 38.52M 35.5M 33.27M 62.16M 4.25B 63.45M 424M 164M 2.05B 167M 163M 7.12B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -6.41% | ||
| 1 week | -7.82% | ||
| Current month | -2.94% | ||
| 1 month | -20.33% | ||
| 3 months | -4.07% | ||
| 6 months | +8.27% | ||
| Current year | +34.12% |
| 1 week | 1.57 |  | 1.79 |
| 1 month | 1.57 | | 2.05 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.7 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.51 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-19 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 01-19 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 24-01-31 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.41% | -7.82% | +106.38% | +37.50% | 45.71M | |
| +1.26% | -1.29% | +31.46% | +353.14% | 31.4B | |
| -1.25% | +1.65% | +2.05% | +21.92% | 21.75B | |
| -0.39% | +4.45% | -24.74% | -42.63% | 7.01B | |
| +0.07% | +10.21% | +0.57% | +81.31% | 4.58B | |
| +0.50% | +4.20% | +7.79% | +63.45% | 2.78B | |
| +12.28% | +8.39% | -13.27% | +866.56% | 1.81B | |
| -2.48% | -2.04% | -20.36% | -67.83% | 1.61B | |
| +2.29% | +3.13% | +18.72% | +0.18% | 1.6B | |
| +0.78% | -0.95% | +13.08% | -34.39% | 1.51B | |
| Average | +0.66% | +2.92% | +12.17% | +127.92% | 7.41B | |
| Weighted average by Cap. | +0.46% | +1.49% | +11.89% | +178.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.72M 37.54M 35.17M 65.72M 4.49B 67.09M 448M 173M 2.17B 176M 172M 7.53B | 38.73M 33.61M 30.98M 29.03M 54.24M 3.71B 55.37M 370M 143M 1.79B 145M 142M 6.22B |
| Net income | 6.7M 5.82M 5.36M 5.02M 9.39M 642M 9.58M 63.95M 24.76M 309M 25.16M 24.62M 1.08B | 24.58M 21.33M 19.66M 18.42M 34.42M 2.35B 35.13M 234M 90.79M 1.13B 92.25M 90.27M 3.94B |
| Net Debt | 4.4M 3.81M 3.52M 3.29M 6.15M 421M 6.28M 41.94M 16.24M 203M 16.5M 16.14M 705M | -1.32M -1.15M -1.06M -991K -1.85M -127M -1.89M -12.61M -4.88M -61.02M -4.96M -4.86M -212M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 1.650 $ | -6.41% | 2,633 |
| 26-06-10 | 1.763 $ | +1.32% | 7,264 |
| 26-06-09 | 1.740 $ | +3.57% | 6,642 |
| 26-06-08 | 1.680 $ | +0.60% | 1,854 |
| 26-06-05 | 1.670 $ | -6.70% | 15,465 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
